Dante Genomics
Hereditary Cancer Panel
Hereditary Cancer Panel
The Dante Hereditary Cancer Panel conducts targeted analysis of 31 well-known oncogenes, ensuring highly efficient detection of variants linked to hereditary cancer. This comprehensive solution analyzes clinically relevant genes with high coverage, delivering results quickly and affordably.
![Hereditary Cancer Panel](http://shop.dantegenomics.com/cdn/shop/files/cancer.png?v=1712915582&width=1445)
Next Generation Sequencing
Next generation sequencing is a valuable and powerful method to assess risk of developing a wide range of hereditary cancers, including: breast, ovary, uterus, prostate, and gastrointestinal malignancies and the probability that such predispositions can be transmitted to future generations.
Main Advantages
- Cost-effective
- Superior sensitivity and specificity
- Higher sequencing depths in the target regions
- Accurate CNV analysis and detection of SNV and INDEL
- Provides information for HRD grade computation
- Short Turnaround times
- User-friendly customizable solutions
Bioinformatic Features
- Primary Analysis (FASTQ)
- Secondary Analysis (VCF, annotation, CNV and Large InDel reporting)
- Tertiary Analysis (Clinical interpretation)